Diabetes Board decisions

The Veteran's type I diabetes mellitus is currently rated at 20 percent, which is the maximum schedular rating available.,Prior to August 12, 2015, the Veteran's bilateral proliferative diabetic retinopathy with retinal bleed and pseudophakia was rated at 30 percent. From August 12, 2015, it has been rated at 40 percent.,The Veteran's bilateral proliferative diabetic retinopathy with retinal bleed and pseudophakia is currently rated at the maximum schedular rating of 40 percent.

The Veteran's claims for service connection for coronary artery disease, colon cancer, and diabetes mellitus, type II are granted. The Board found that the Veteran had a current diagnosis of coronary artery disease that began during active service.

The Veteran's claim for TDIU prior to October 22, 2020 was denied as he did not meet the schedular criteria for a TDIU rating due to his service-connected disabilities. The Board found that the Veteran had some capacity for substantially gainful employment despite his service-connected conditions.

The Veteran's claim for service connection for chronic kidney disease as secondary to his service-connected diabetes mellitus, type II and hypertension is granted.

The Board has remanded the case due to a new theory of entitlement presented by the Veteran's representative, suggesting that OSA is secondary to service-connected diabetes. The Board requests an addendum opinion from a sleep disorder specialist to address whether OSA is proximately caused or underwent any incremental increase in disability due to service-connected diabetes.

The Board has determined that the Veteran's service-connected disabilities preclude him from securing and following substantially gainful employment prior to September 5, 2018. The decision grants a total disability rating based on individual unemployability (TDIU) for this period.

The Veteran's service-connected disabilities, including PTSD, diabetes, bilateral hearing loss, tinnitus, peripheral neuropathy, and erectile dysfunction, have rendered him unable to secure or follow substantially gainful employment. The Board has granted TDIU based on the severity of his disabilities.

The Veteran's claim for service connection for diabetes mellitus, type II was denied. The Board also found that the Veteran is not entitled to a TDIU prior to October 11, 2004.

The Board has dismissed all claims for service connection as they have been fully granted in the May 2020 and September 2020 rating decisions.

The Board denied the Veteran's claims for service connection for diabetes mellitus, bilateral upper extremity neuropathy, and a bilateral knee disability due to lack of current diagnoses in the medical records.

The Veteran's increased rating for diabetes mellitus type II was denied, and the issue of service connection for bilateral lower extremity diabetic neuropathy as a separate compensable complication of his service-connected diabetes mellitus type II is remanded.

The Veteran's appeal is remanded for additional medical opinions regarding his service connection claims, including the need to obtain VA and private treatment records.

The Board has remanded the claims for service connection for type 2 diabetes mellitus, chronic kidney disease, gout, glaucoma, liver disease, hernia, and thyroid disability due to in-service exposure at Camp Lejeune. The claims are pending as new and material evidence was submitted by the Appellant.

The Veteran's service-connected disabilities prevented him from engaging in substantially gainful employment, and the Board has granted an earlier effective date of July 23, 2018 for his total disability rating based on individual unemployability (TDIU).

The Veteran's service connection claims for coronary artery disease, type 2 diabetes mellitus, and peripheral neuropathy of the lower extremities have been granted. However, his claim for peripheral neuropathy of the right and left lower extremities secondary to type 2 diabetes mellitus is remanded due to a duty-to-assist error.

The Veteran's claims for higher initial disability ratings and earlier effective dates for his service-connected diabetes mellitus type 2 were denied. The Board found that the evidence did not support a rating in excess of 20 percent prior to January 6, 2014, or an earlier effective date prior to February 26, 2013.

The Board has remanded the claims for service connection for a pancreas condition, prostate cancer, glaucoma, macular pigment change, and age-related cataract (claimed as latanoprost of the left eye), and diabetes mellitus due to duty assist errors. A VA medical opinion is needed regarding the etiology of these conditions.

The Board has decided to remand the case due to insufficient evidence regarding the Veteran's exposure to Agent Orange or similar herbicides during service, and a new medical opinion is needed to determine if his Type II Diabetes is related to his in-service exposures.

The Veteran's initial ratings for diabetes mellitus and prostate cancer have been granted, with a 40 percent rating assigned for each condition. The effective dates are not specified as the claims were initially filed on November 28, 2016.

The Veteran's service connection claims for diabetes mellitus type II, tinea pedis and tinea cruris were denied as there was no credible evidence of herbicide agent exposure or actual exposure to Agent Orange. The SMC claim for loss of use of a creative organ due to erectile dysfunction resulting from diabetes was also denied.